ID

39453

Description

Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack; ODM derived from: https://clinicaltrials.gov/show/NCT01438086

Link

https://clinicaltrials.gov/show/NCT01438086

Keywords

Versions (1)
  1. 1/11/20 1/11/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 11, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Heart Failure NCT01438086

English

Eligibility Heart Failure NCT01438086

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 - 75
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
presents within 2-12 hours of at least 30 minutes of myocardial ischemic pain
Description

ischemic pain Myocardial Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0745417
UMLS CUI [1,2]
C1522564
UMLS CUI [1,3]
C0449238
ecg evidence of myocardial infarction
Description

ECG Myocardial infarction

Data type

boolean

Alias
UMLS CUI [1]
C0428953
undergoing percutaneous coronary intervention (pci) for st-elevation myocardial infarction
Description

Percutaneous Coronary Intervention ST segment elevation myocardial infarction

Data type

boolean

Alias
UMLS CUI [1,1]
C1532338
UMLS CUI [1,2]
C1536220
left ventricular ejection fraction during pci of 40% or less
Description

Left ventricular ejection fraction During Percutaneous Coronary Intervention

Data type

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C1532338
timi flow grade 3 in the infarct-related artery following reperfusion and stenting
Description

TIMI Flow Grade | Artery Infarct Related | Status post Reperfusion | Status post Stenting

Data type

boolean

Alias
UMLS CUI [1,1]
C3272266
UMLS CUI [1,2]
C0441800
UMLS CUI [2,1]
C0003842
UMLS CUI [2,2]
C0021308
UMLS CUI [2,3]
C0439849
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0035124
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C2348535
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of prior myocardial infarction
Description

History of myocardial infarction

Data type

boolean

Alias
UMLS CUI [1]
C1275835
prior history of heart failure, left ventricular dysfunction or cardiomyopathy
Description

History of heart failure | Left Ventricular Dysfunction Previous | History of cardiomyopathy

Data type

boolean

Alias
UMLS CUI [1]
C0455531
UMLS CUI [2,1]
C0242698
UMLS CUI [2,2]
C0205156
UMLS CUI [3]
C4039015
active or suspected neoplasia
Description

Neoplastic disease | Neoplastic disease Suspected

Data type

boolean

Alias
UMLS CUI [1]
C1882062
UMLS CUI [2,1]
C1882062
UMLS CUI [2,2]
C0750491
known impaired liver function
Description

Liver Dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C0086565
cardiogenic shock
Description

Shock, Cardiogenic

Data type

boolean

Alias
UMLS CUI [1]
C0036980
estimated glomerular filtration rate < 45 ml/min/1.73m2
Description

Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C3811844
history of hypoglycaemia requiring hospitalisation
Description

Hypoglycemia Hospitalization Required

Data type

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C1708385
history of primary insulin-like growth factor-1 deficiency or growth hormone disorders
Description

Primary insulin like growth factor-1 deficiency | Disorder of human growth hormone

Data type

boolean

Alias
UMLS CUI [1]
C3160868
UMLS CUI [2]
C1295597
contraindication to cardiac magnetic resonance imaging
Description

Medical contraindication Magnetic Resonance Imaging of Heart

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0412692
pregnancy or nursing mothers
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known allergy to study drug or any of its inactive ingredients
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drug Inactive ingredient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C1552019
treatment with another investigational agent within 30 days of enrolment
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
subjects unable or unwilling to comply with follow-up requirements of study
Description

Compliance behavior Unable Follow-up | Compliance behavior Unwilling Follow-up

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C1299582
UMLS CUI [1,3]
C3274571
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0558080
UMLS CUI [2,3]
C3274571
subjects unable to provide written informed consent
Description

Informed Consent Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Back to the top of the page

Similar models

Eligibility Heart Failure NCT01438086

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 - 75
boolean
C0001779 (UMLS CUI [1])
ischemic pain Myocardial Duration
Item
presents within 2-12 hours of at least 30 minutes of myocardial ischemic pain
boolean
C0745417 (UMLS CUI [1,1])
C1522564 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
ECG Myocardial infarction
Item
ecg evidence of myocardial infarction
boolean
C0428953 (UMLS CUI [1])
Percutaneous Coronary Intervention ST segment elevation myocardial infarction
Item
undergoing percutaneous coronary intervention (pci) for st-elevation myocardial infarction
boolean
C1532338 (UMLS CUI [1,1])
C1536220 (UMLS CUI [1,2])
Left ventricular ejection fraction During Percutaneous Coronary Intervention
Item
left ventricular ejection fraction during pci of 40% or less
boolean
C0428772 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
TIMI Flow Grade | Artery Infarct Related | Status post Reperfusion | Status post Stenting
Item
timi flow grade 3 in the infarct-related artery following reperfusion and stenting
boolean
C3272266 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0003842 (UMLS CUI [2,1])
C0021308 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0035124 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C2348535 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
History of myocardial infarction
Item
history of prior myocardial infarction
boolean
C1275835 (UMLS CUI [1])
History of heart failure | Left Ventricular Dysfunction Previous | History of cardiomyopathy
Item
prior history of heart failure, left ventricular dysfunction or cardiomyopathy
boolean
C0455531 (UMLS CUI [1])
C0242698 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C4039015 (UMLS CUI [3])
Neoplastic disease | Neoplastic disease Suspected
Item
active or suspected neoplasia
boolean
C1882062 (UMLS CUI [1])
C1882062 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Liver Dysfunction
Item
known impaired liver function
boolean
C0086565 (UMLS CUI [1])
Shock, Cardiogenic
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
estimated glomerular filtration rate < 45 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Hypoglycemia Hospitalization Required
Item
history of hypoglycaemia requiring hospitalisation
boolean
C0020615 (UMLS CUI [1,1])
C1708385 (UMLS CUI [1,2])
Primary insulin like growth factor-1 deficiency | Disorder of human growth hormone
Item
history of primary insulin-like growth factor-1 deficiency or growth hormone disorders
boolean
C3160868 (UMLS CUI [1])
C1295597 (UMLS CUI [2])
Medical contraindication Magnetic Resonance Imaging of Heart
Item
contraindication to cardiac magnetic resonance imaging
boolean
C1301624 (UMLS CUI [1,1])
C0412692 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or nursing mothers
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drug Inactive ingredient
Item
known allergy to study drug or any of its inactive ingredients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1552019 (UMLS CUI [2,3])
Investigational New Drugs
Item
treatment with another investigational agent within 30 days of enrolment
boolean
C0013230 (UMLS CUI [1])
Compliance behavior Unable Follow-up | Compliance behavior Unwilling Follow-up
Item
subjects unable or unwilling to comply with follow-up requirements of study
boolean
C1321605 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C1321605 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C3274571 (UMLS CUI [2,3])
Informed Consent Unable
Item
subjects unable to provide written informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial